Drug Target Review – Issue 4 2020

Posted: 26 November 2020 | | No comments yet

In this journal, find articles discussing antimicrobial resistance, exploring why inhibiting the interaction between SARS-CoV-2 and neuropilin-1 could help combat COVID-19, as well as how CRISPR can be used to enhance productivity in cell line development. Also in this issue, features on engineering new biologic drugs and precision medicine.

Included in this issue:

    Genetic screening to predict the risk of future diseases
    Pushpanathan Muthuirulan, Harvard University
    Antimicrobial resistance – a public health emergency on the horizon
    Jack Kay, University of Plymouth and Ingenza Ltd
  • COVID-19
    Development of a physiologically relevant lung model for understanding SARS-CoV-2 infection
    Lyle Armstrong, Newcastle University and Newcells Biotech
    Investigating cellular pathways driving severe COVID-19 with proteomics
    Mike Filbin, Massachusetts General Hospital
    A label-free imaging technique for drug evaluation at single‑cell level
    Arno Germond, RIKEN Center for Biosystems Dynamics Research
    Biosynthetic polysaccharidebased drugs and nutraceuticals from non-animal sources
    Robert J Linhardt and Payel Datta, Rensselaer Polytechnic Institute
  • NGS
    Tracking SARS-CoV- 2 with genome sequencing
    Nikki Withers, Drug Target Review
    Predicting COVID-19 susceptibility and severity
    Cathy Ball, AncestryDNA

The rest of this content is restricted - login or subscribe free to access

Screening the future innovations in drug discoveryThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here